Patents by Inventor Harry Gristick

Harry Gristick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250144197
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Application
    Filed: January 9, 2025
    Publication date: May 8, 2025
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick
  • Patent number: 12239698
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 4, 2025
    Assignees: The Rockefeller University, California Institute of Technology
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick
  • Publication number: 20240033341
    Abstract: Provided herein are HIV immunogens and uses thereof for generating an immune response in a subject. This disclosure further provides a method for treating or preventing a human immunodeficiency type I (HIV-I) infection in a subject using the disclosed HIV immunogens and/or antibodies generated by any of the methods disclosed herein.
    Type: Application
    Filed: June 22, 2023
    Publication date: February 1, 2024
    Inventors: Harry Gristick, Pamela J. Bjorkman, Harald Hartweger, Michel C. Nussenzweig
  • Publication number: 20220031830
    Abstract: This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
    Type: Application
    Filed: November 27, 2019
    Publication date: February 3, 2022
    Inventors: Michel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick